Pages that link to "Item:Q4668352"

The following pages link to Adaptive Sample Size Calculations in Group Sequential Trials (Q4668352):

Displaying 46 items.

• Adaptive designs with arbitrary dependence structure based on Fisher's combination test (Q893018) (← links)
• Adaptive confidence intervals of desired length and power for normal means (Q989256) (← links)
• Basic concepts of group sequential and adaptive group sequential test procedures (Q1580842) (← links)
• Sequential monitoring of response-adaptive randomized clinical trials with sample size re-estimation (Q2301050) (← links)
• Optimal two-stage group-sequential designs (Q2475735) (← links)
• (Q2701875) (← links)
• (Q2755673) (← links)
• Adaptive designs with arbitrary dependence structure (Q2874295) (← links)
• A comparison of methods for constructing confidence intervals after phase II/III clinical trials (Q2874297) (← links)
• Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications (Q2875756) (← links)
• An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size (Q2927605) (← links)
• Adaptive designs for subpopulation analysis optimizing utility functions (Q2938308) (← links)
• Adaptive dose-finding: Proof of concept with type I error control (Q3056472) (← links)
• Internal pilots for observational studies (Q3056474) (← links)
• Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches (Q3078835) (← links)
• Monitoring Clinical Trials with Multiple Arms (Q3078836) (← links)
• Sequential Tests for Noninferiority and Superiority (Q3079082) (← links)
• Statistical Inference in Adaptive Group Sequential Trials with the Standardized Mean Difference as Effect Size (Q3083473) (← links)
• An Approach to the Conditional Error Rate Principle with Nuisance Parameters (Q3100810) (← links)
• Adaptive Design for Censored Survival Data Adjusting for Covariates (Q3430296) (← links)
• Are Flexible Designs Sound? (Q3436501) (← links)
• Optimal Conditional Error Functions for the Control of Conditional Power (Q3445294) (← links)
• Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials (Q3527716) (← links)
• <i>α</i>-Investing: a Procedure for Sequential Control of Expected False Discoveries (Q3541272) (← links)
• Development of Adaptive Group Sequential Procedure for Changing Sample Size (Q3577219) (← links)
• Exact Confidence Bounds Following Adaptive Group Sequential Tests (Q3637002) (← links)
• Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs (Q4430337) (← links)
• Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials (Q4649069) (← links)
• Interim Analysis and Sample Size Reassessment (Q4670476) (← links)
• Interim Design Modifications in Time-to-Event Studies (Q4916467) (← links)
• Confidence intervals for the selected population in randomized trials that adapt the population enrolled (Q4921950) (← links)
• Partition testing in confirmatory adaptive designs with structured objectives (Q4921952) (← links)
• Adaptive Multivariate Global Testing (Q4975403) (← links)
• SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION (Q5066789) (← links)
• A note on the shape of sample size functions of optimal adaptive two-stage designs (Q5079909) (← links)
• Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes (Q5107700) (← links)
• <i>p</i>-Value calculation for multi-stage additive tests (Q5454212) (← links)
• Monitoring Continuous Long-Term Outcomes in Adaptive Designs (Q5460707) (← links)
• Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations (Q5714618) (← links)
• Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers (Q6055528) (← links)
• Adaptive enrichment designs with a continuous biomarker (Q6055888) (← links)
• Discussion on “Adaptive enrichment designs with a continuous biomarker” by N. Stallard (Q6055892) (← links)
• Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events (Q6068480) (← links)
• Optimization of adaptive designs with respect to a performance score (Q6068637) (← links)
• Improving adaptive seamless designs through Bayesian optimization (Q6089921) (← links)
• Exact change point detection with improved power in small‐sample binomial sequences (Q6091720) (← links)